KRAS P.G12C Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
KRAS P.G12C
Gustave Roussy, Cancer Campus, Grand Paris40 enrolled5 locationsNCT05631249
Recruiting
Phase 1Phase 2
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
Non-small Cell Lung CancerKRAS P.G12C
Allist Pharmaceuticals, Inc.240 enrolled27 locationsNCT05288205